Skip to main content

Joan Compte Barrón

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Joan Compte Barrón

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Projects

Malalties neurodegeneratives

IP: Miquel Vila Bover
Collaborators: Jorge Hernández Vara, Joan Compte Barrón, Marta Martínez Vicente, Jordi Bove Badell, Malalties neurodegeneratives , Maria Camprodon Gomez, Malalties neurodegeneratives , Camille Guillard Sirieix, Marina Lorente Picón, Laura Castillo Ribelles, Oriol de Fabregues-Boixar Nebot, Javier Hoyo Pérez, Ariadna Laguna Tuset, Thais Cuadros Arasa, Jordi Riera Heredia, David Ramos Vicente, Malalties neurodegeneratives , Malalties neurodegeneratives , Helena Xicoy Cortada, Alba Nicolau Vera, Marta González Sepúlveda, Malalties neurodegeneratives , Joana Margalida Cladera Sastre, Annabelle Parent, Daniela Samaniego Toro, Malalties neurodegeneratives
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 40000
Reference: 2021 SGR 00784
Duration: 01/01/2022 - 31/12/2024

Activity and connectivity drive neuronal vulnerability and disease progression in Parkinson's disease

IP: Miquel Vila Bover
Collaborators: Joan Compte Barrón, Javier Hoyo Pérez, Gerard Roch Alba, Marta González Sepúlveda, Ariadna Laguna Tuset, Joana Margalida Cladera Sastre
Funding agency: Michael J. Fox Foundation
Funding: 1269495.05
Reference: ASAP_MJFF2021
Duration: 01/11/2021 - 31/10/2024

Development of a novel genetically-engineered humanized rodent model to study neuronal dysfunction and neurodegeneration in Parkinson's disease and brain aging

IP: Miquel Vila Bover
Collaborators: Joan Compte Barrón, Miriam Izquierdo Sans
Funding agency: Fundació "La Caixa"
Funding: 115092
Reference: CAIXA/INPHINIT/COMPTE
Duration: 01/10/2018 - 30/09/2021

Related news

Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at VHIR, is the co-chair of the local organising committee. And Dr. Ariadna Laguna, principal investigator of the same group, is a scientific ambassador.

Researchers describe the molecular mechanisms by which the GBA gene, the main genetic risk factor, associates with the accumulation of α-synuclein in neurons.

It is the project “New Nanotechnological Therapy for Parkinson’s disease: Nose to Brain Delivery of GBA-Polymer Nanoconjugates (nanoGBAtoBrain)”.

Related professionals

Marc Martí Gallostra

Marc Martí Gallostra

Main researcher
General Surgery
Read more
Deborah Pareto Onghena

Deborah Pareto Onghena

Main researcher
Neuroradiology
Read more
Mª Dolores Braquehais Conesa

Mª Dolores Braquehais Conesa

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Lucas Rivera Sánchez

Lucas Rivera Sánchez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.